Abstract |
Chikungunya virus (CHIKV) infection, a febrile illness caused by a mosquito-transmitted alphavirus, has afflicted millions of people worldwide. There is currently no approved effective antiviral treatment for CHIKV infection. In this study, we report a new class of small-molecule CHIKV inhibitors, the oxindole- labdanes, that potently block the replication of CHIKV with good selectivity. Andrographolide, a previously reported inhibitor of CHIKV infection, was used as the lead compound for our initial structure-activity relationship (SAR) study. From a focused library of 72 andrographolide analogues, we identified the lead compound (E)-2 with improved antiviral activities. Further optimization of (E)-2 led to the discovery of the normal- labdane 7-chloro-oxindole (E)-42 as potent inhibitor against two low-passage CHIKV isolates from human patients with an EC50 of 1.55 μM against CHIKV-122508 and 0.14 μM against CHIKV-6708. Compound (E)-42 displayed minimal cytotoxic liability (CC50 > 100 μM), thus furnishing good selectivity relative to the host cells. Mechanistically, (E)-42 does not inactivate the viral particles but rather acts on the host cells to interfere with the viral replication, demonstrating both prophylactic and therapeutic effects. Our findings open a new avenue for the development of oxindole- labdane compounds as promising antiviral drugs against CHIKV infection.
|
Authors | Quy Thi Ngoc Tran, Regina Ching Hua Lee, Hon Jin Liu, Danli Ran, Vincent Zhan Lin Low, Dong Quang To, Justin Jang Hann Chu, Christina Li Lin Chai |
Journal | European journal of medicinal chemistry
(Eur J Med Chem)
Vol. 230
Pg. 114110
(Feb 15 2022)
ISSN: 1768-3254 [Electronic] France |
PMID | 35085859
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Antiviral Agents
- Diterpenes
- Oxindoles
- RNA, Viral
- labdane
|
Topics |
- Animals
- Antiviral Agents
(pharmacology, therapeutic use)
- Chikungunya Fever
(drug therapy)
- Diterpenes
(pharmacology, therapeutic use)
- Humans
- Oxindoles
(pharmacology)
- RNA, Viral
- Virus Replication
|